Capricor Therapeutics
CAPR
#7980
Rank
ยฃ0.21 B
Marketcap
ยฃ4.77
Share price
-4.36%
Change (1 day)
-59.68%
Change (1 year)

Capricor Therapeutics (CAPR) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ73.9 Million

According to Capricor Therapeutics 's latest financial reports the company has ยฃ73.9 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Capricor Therapeutics - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.12 B289.54%
2023-12-31ยฃ30.99 M-9.47%
2022-12-31ยฃ34.23 M32.48%
2021-12-31ยฃ25.84 M7.84%
2020-12-31ยฃ23.96 M217.9%
2019-12-31ยฃ7.53 M31.87%
2018-12-31ยฃ5.71 M-45.3%
2017-12-31ยฃ10.45 M-20.37%
2016-12-31ยฃ13.12 M43.36%
2015-12-31ยฃ9.15 M77.4%
2014-12-31ยฃ5.16 M314.03%
2013-12-31ยฃ1.24 M-53.82%
2012-12-31ยฃ2.69 M303.73%
2011-12-31ยฃ0.66 M-69.45%
2010-12-31ยฃ2.18 M11.51%
2009-12-31ยฃ1.96 M-47.71%
2008-12-31ยฃ3.75 M-54.07%
2007-12-31ยฃ8.17 M
2005-12-31ยฃ0 M-50.74%
2004-12-31ยฃ0 M-45.16%
2003-12-31ยฃ0 M3768.64%
2002-12-31ยฃ0 M-85.51%
2001-12-31ยฃ0 M-98.78%
2000-12-31ยฃ0 M
1999-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Cytokinetics
CYTK
ยฃ0.72 B 876.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
ยฃ1.88 M-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ13.91 B 18,732.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.83 B 1,031.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ0.43 B 491.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
ยฃ2.28 M-96.91%๐Ÿ‡บ๐Ÿ‡ธ USA